Adverse effects during treatment ‐ pain in abdomen · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ pain in abdomen compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Progression of endometrial hyperplasia to endometrial cancer · endometrial hyperplasia
1 finding from 1 review
Hysterectomy rate · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin changes hysterectomy rate compared with megestrol (very low certainty).
1 finding from 1 review
Abnormal uterine bleeding · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin changes abnormal uterine bleeding compared with megestrol (very low certainty).
1 finding from 1 review
HRQOL ‐ not measured · endometrial hyperplasia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects during treatment ‐ not reported · endometrial hyperplasia
The review found no eligible studies for this question.
1 finding from 1 review
Regression of endometrial hyperplasia (with or without atypia) to proliferative, secretory, or atrophic endometrium · endometrial hyerplasia
Summary of findings table ‐ Metformin + megestrol may leads to higher regression of endometrial hyperplasia (with or without atypia) to… compared with megestrol (low certainty).
1 finding from 1 review
Recurrence of endometrial hyperplasia · endometrial hyerplasia
1 finding from 1 review
Proven sepsis (positive bacterial culture, local or systemic) · neonates born from 35 weeks of gestation who have underdone gastrointestinal surgery
Summary of findings table ‐ Probiotics showed no clear difference in proven sepsis (positive bacterial culture, local or systemic) compared with placebo (low certainty).
1 finding from 1 review
Neonatal mortality · neonates born from 35 weeks of gestation who have underdone gastrointestinal surgery
1 finding from 1 review
Age at full enteral feedings (days) · neonates born from 35 weeks of gestation who have underdone gastrointestinal surgery
1 finding from 1 review
Mortality before hospital discharge · neonates born from 35 weeks of gestation who have underdone gastrointestinal surgery
1 finding from 1 review
Non‐pathogenic intestinal microflora (relative abundance) · neonates born from 35 weeks of gestation who have underdone gastrointestinal surgery
1 finding from 1 review
Intervention not reported
Body weight change (kg) · participants living with overweight or obesity
1 finding from 1 review
Intervention not reported
Health‐related quality of life · participants living with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · participants living with overweight or obesity
1 finding from 1 review
Intervention not reported
All‐cause mortality · participants living with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Morbidity · participants living with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Anthropometric measures other than body weight a) BMI b) Waist circumference c) Fat mass · participants living with overweight or obesity
1 finding from 1 review
Behaviour: aggressive or violent behaviour · aggressive behaviour in schizophrenia
Structured risk assessment probably leads to lower scientific behaviour: aggression – clinically important change in… compared with standard professional care (moderate certainty).
1 finding from 1 review